PainReform Ltd. (PRFX)
NASDAQ: PRFX · IEX Real-Time Price · USD
1.784
+0.004 (0.22%)
Mar 28, 2024, 12:43 PM EDT - Market open

PainReform Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Selling, General & Admin
3.554.454.351.320.550.28
Research & Development
6.044.422.860.350.140.22
Operating Expenses
9.588.877.211.670.690.5
Operating Income
-9.58-8.87-7.21-1.67-0.69-0.5
Interest Expense / Income
-0.25-0.090.030.990.590.33
Other Expense / Income
---1.18--
Pretax Income
-9.34-8.78-7.24-3.83-1.28-0.83
Income Tax
0.010.010.010.2200
Net Income
-9.34-8.79-7.25-4.05-1.28-0.83
Shares Outstanding (Basic)
111000
Shares Outstanding (Diluted)
111000
Shares Change
21.00%8.22%208.13%462.64%--
EPS (Basic)
-7.14-8.13-7.25-12.50-41.70-32.40
EPS (Diluted)
-7.14-8.13-7.25-12.50-41.70-32.40
Free Cash Flow
-6.69-6.47-6.6-2.57-0.61-0.64
Free Cash Flow Per Share
-5.11-5.98-6.61-7.91-10.56-11.01
EBITDA
-9.57-8.85-7.2-2.85-0.69-0.5
Depreciation & Amortization
0.020.020.01000
EBIT
-9.58-8.87-7.21-2.85-0.69-0.5
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).